Unknown

Dataset Information

0

Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.

ABSTRACT:

SUBMITTER: Cates CJ 

PROVIDER: S-EPMC6524619 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
| S-EPMC4015852 | biostudies-literature
Unknown Interventions to improve adherence to inhaled steroids for asthma.
| S-EPMC6478134 | biostudies-literature
Unknown Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
| S-EPMC2104614 | biostudies-other
Unknown Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
| S-EPMC5108502 | biostudies-literature
Unknown Serious adverse events during ruxolitinib treatment discontinuation in patients with myelofibrosis.
| S-EPMC3228619 | biostudies-literature
Unknown Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial.
| S-EPMC7495966 | biostudies-literature
Unknown Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring.
| S-EPMC6887964 | biostudies-literature
Unknown Embedding surveillance into clinical care to detect serious adverse events in pregnancy.
| S-EPMC4817214 | biostudies-literature
Unknown Serious adverse events of older adults in nursing home and community intervention trials.
| S-EPMC5898490 | biostudies-literature
Unknown Active surveillance of serious adverse events following transfusion of COVID-19 convalescent plasma.
| S-EPMC8661846 | biostudies-literature